EA201590014A1 - Азетидиновые и пиперидиновые соединения, подходящие для применения в качестве ингибиторов pde10 - Google Patents

Азетидиновые и пиперидиновые соединения, подходящие для применения в качестве ингибиторов pde10

Info

Publication number
EA201590014A1
EA201590014A1 EA201590014A EA201590014A EA201590014A1 EA 201590014 A1 EA201590014 A1 EA 201590014A1 EA 201590014 A EA201590014 A EA 201590014A EA 201590014 A EA201590014 A EA 201590014A EA 201590014 A1 EA201590014 A1 EA 201590014A1
Authority
EA
Eurasian Patent Office
Prior art keywords
azetidine
piperidine compounds
compounds suitable
pde10 inhibitors
methods
Prior art date
Application number
EA201590014A
Other languages
English (en)
Russian (ru)
Inventor
Дженнифер Р. Аллен
Цзянь Дж. Чэнь
Майкл Дж. Фрон
Мэттью Ричард Кэллер
Циниань Лю
Томас Т. Нгуйен
Александер Дж. Пикрелл
Вэньюань Цянь
Роберт М. Рзаса
Вэнэ Чжун
Original Assignee
Эмджен Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48692687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201590014(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Эмджен Инк. filed Critical Эмджен Инк.
Publication of EA201590014A1 publication Critical patent/EA201590014A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
EA201590014A 2012-06-14 2013-06-14 Азетидиновые и пиперидиновые соединения, подходящие для применения в качестве ингибиторов pde10 EA201590014A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261659911P 2012-06-14 2012-06-14
PCT/US2013/045768 WO2013188724A1 (en) 2012-06-14 2013-06-14 Azetidine and piperidine compounds useful as pde10 inhibitors

Publications (1)

Publication Number Publication Date
EA201590014A1 true EA201590014A1 (ru) 2015-04-30

Family

ID=48692687

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201590014A EA201590014A1 (ru) 2012-06-14 2013-06-14 Азетидиновые и пиперидиновые соединения, подходящие для применения в качестве ингибиторов pde10

Country Status (25)

Country Link
US (3) US8691986B2 (cg-RX-API-DMAC7.html)
EP (1) EP2864317A1 (cg-RX-API-DMAC7.html)
JP (1) JP2015519402A (cg-RX-API-DMAC7.html)
KR (1) KR20150023417A (cg-RX-API-DMAC7.html)
CN (1) CN104619694A (cg-RX-API-DMAC7.html)
AP (1) AP2014008136A0 (cg-RX-API-DMAC7.html)
AR (1) AR091436A1 (cg-RX-API-DMAC7.html)
AU (1) AU2013274153B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014031368A2 (cg-RX-API-DMAC7.html)
CA (1) CA2875802A1 (cg-RX-API-DMAC7.html)
CL (1) CL2014003391A1 (cg-RX-API-DMAC7.html)
CO (1) CO7160011A2 (cg-RX-API-DMAC7.html)
CR (1) CR20150012A (cg-RX-API-DMAC7.html)
EA (1) EA201590014A1 (cg-RX-API-DMAC7.html)
HK (1) HK1203935A1 (cg-RX-API-DMAC7.html)
IL (1) IL235901A0 (cg-RX-API-DMAC7.html)
MA (1) MA37748B1 (cg-RX-API-DMAC7.html)
MX (1) MX2014014924A (cg-RX-API-DMAC7.html)
PE (1) PE20150348A1 (cg-RX-API-DMAC7.html)
PH (1) PH12014502780A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201408168UA (cg-RX-API-DMAC7.html)
TN (1) TN2014000510A1 (cg-RX-API-DMAC7.html)
TW (1) TWI508959B (cg-RX-API-DMAC7.html)
UY (1) UY34858A (cg-RX-API-DMAC7.html)
WO (1) WO2013188724A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103221404B (zh) 2010-05-13 2015-12-16 安姆根有限公司 可用作pde10抑制剂的不饱和氮杂环化合物
AR091436A1 (es) * 2012-06-14 2015-02-04 Amgen Inc Compuestos de azetidina y piperidina utiles como inhibidores de pde10

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
CN103221404B (zh) 2010-05-13 2015-12-16 安姆根有限公司 可用作pde10抑制剂的不饱和氮杂环化合物
CA2800578A1 (en) * 2010-05-13 2011-11-17 Amgen Inc. Nitrogen-heterocyclic compounds as phosphodiesterase 10 inhibitors
EP2569302A1 (en) * 2010-05-13 2013-03-20 Amgen, Inc Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
US8952037B2 (en) * 2010-05-13 2015-02-10 Amgen Inc. Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
AR091436A1 (es) * 2012-06-14 2015-02-04 Amgen Inc Compuestos de azetidina y piperidina utiles como inhibidores de pde10

Also Published As

Publication number Publication date
AU2013274153A1 (en) 2014-12-18
JP2015519402A (ja) 2015-07-09
WO2013188724A1 (en) 2013-12-19
MA37748A1 (fr) 2016-11-30
HK1203935A1 (en) 2015-11-06
US20140148435A1 (en) 2014-05-29
MX2014014924A (es) 2015-03-09
CO7160011A2 (es) 2015-01-15
TN2014000510A1 (en) 2016-03-30
TW201412729A (zh) 2014-04-01
US8691986B2 (en) 2014-04-08
US9303028B2 (en) 2016-04-05
PE20150348A1 (es) 2015-03-04
PH12014502780A1 (en) 2015-02-02
UY34858A (es) 2013-11-29
CR20150012A (es) 2015-02-11
US20130338138A1 (en) 2013-12-19
AR091436A1 (es) 2015-02-04
MA37748B1 (fr) 2017-07-31
AP2014008136A0 (en) 2014-12-31
BR112014031368A2 (pt) 2017-06-27
US9493459B2 (en) 2016-11-15
CL2014003391A1 (es) 2015-07-10
AU2013274153B2 (en) 2016-05-19
SG11201408168UA (en) 2015-01-29
IL235901A0 (en) 2015-09-24
KR20150023417A (ko) 2015-03-05
CA2875802A1 (en) 2013-12-19
CN104619694A (zh) 2015-05-13
EP2864317A1 (en) 2015-04-29
TWI508959B (zh) 2015-11-21
US20160176874A1 (en) 2016-06-23

Similar Documents

Publication Publication Date Title
EA201291236A1 (ru) Азотные гетероциклические соединения, применимые в качестве ингибиторов pde10
IN2014KN02601A (cg-RX-API-DMAC7.html)
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
EA201990240A1 (ru) Новые трициклические соединения в качестве противораковых средств
EA201490357A1 (ru) Индазолы
EA201691272A1 (ru) Тетрагидропиридопиразины в качестве модуляторов gpr6
EA024842B9 (ru) Соединения в качестве модуляторов протеинкиназы pi3k
MX2013012776A (es) Inhibidores de la tirosina cinasa de bazo que contienen aminopiridina.
EA201100749A1 (ru) Производные пиридина и пиримидина в качестве ингибиторов фосфодиэстеразы 10
UA112795C2 (uk) Біциклічні піразинонові похідні
EA201400624A1 (ru) Замещенные 4-фенилпиридины для лечения болезней, связанных с рецептором nk-1
EA201500182A1 (ru) 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ
MX2016007128A (es) Compuestos del receptor 6 de quimiocina (ccr6).
NZ730334A (en) Substituted 2-azabicycles and their use as orexin receptor modulators
EA201790207A1 (ru) Новые замещенные пиримидиновые соединения
EA201790519A1 (ru) Терапевтические соединения в качестве ингибиторов рецептора орексина-1
EA201790253A1 (ru) Ингибиторы альдостеронсинтазы
EA201790830A1 (ru) Ингибиторы альдостеронсинтазы
EA201691413A1 (ru) Селективные антагонисты nr2b
UA117779C2 (uk) Піразини як модулятори gpr6
MX381643B (es) Compuestos heteroarilo bicíclicos sustituidos como agonistas rxr.
EA201691133A1 (ru) (r)-3-((3s,4s)-3-фтор-4-(4-гидроксифенил)пиперидин-1-ил)-1-(4-метилбензил)пирролидин-2-он и его пролекарственные средства для лечения психиатрических нарушений
EA201491878A8 (ru) Замещенные ксантиновые производные
PH12014502780A1 (en) Azetidine and piperidine compounds useful as pde10 inhibitors
MX2014002343A (es) Inhibidores de parp.